User profiles for Frank J DeFalco
 | Frank J DeFalcoJanssen Research & Development Verified email at its.jnj.com Cited by 1497 |
Characterizing treatment pathways at scale using the OHDSI network
…, MJ Schuemie, FJ DeFalco… - Proceedings of the …, 2016 - National Acad Sciences
Observational research promises to complement experimental research by providing large,
diverse populations that would be infeasible for an experiment. Observational research can …
diverse populations that would be infeasible for an experiment. Observational research can …
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases
… Frank J DeFalco , Frank J DeFalco … Erica A Voss, Rupa Makadia, Amy Matcho, Qianli Ma,
Chris Knoll, Martijn Schuemie, Frank J DeFalco, Ajit Londhe, Vivienne Zhu, Patrick B Ryan, …
Chris Knoll, Martijn Schuemie, Frank J DeFalco, Ajit Londhe, Vivienne Zhu, Patrick B Ryan, …
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: a retrospective cohort …
Z Yuan, FJ DeFalco, PB Ryan… - Diabetes, Obesity …, 2018 - Wiley Online Library
Aims To examine the incidence of amputation in patients with type 2 diabetes mellitus (T2DM)
treated with sodium glucose co‐transporter 2 (SGLT2) inhibitors overall, and canagliflozin …
treated with sodium glucose co‐transporter 2 (SGLT2) inhibitors overall, and canagliflozin …
Increasing trust in real-world evidence through evaluation of observational data quality
Objective Advances in standardization of observational healthcare data have enabled
methodological breakthroughs, rapid global collaboration, and generation of real-world evidence …
methodological breakthroughs, rapid global collaboration, and generation of real-world evidence …
[HTML][HTML] Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …
[HTML][HTML] Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents
Y Wang, M Desai, PB Ryan, FJ DeFalco… - Diabetes research and …, 2017 - Elsevier
Aims To estimate and compare incidence of diabetes ketoacidosis (DKA) among patients
with type 2 diabetes who are newly treated with SGLT2 inhibitors (SGLT2i) versus non-SGLT2i …
with type 2 diabetes who are newly treated with SGLT2 inhibitors (SGLT2i) versus non-SGLT2i …
[HTML][HTML] Multisite evaluation of a data quality tool for patient-level clinical data sets
Methods: We describe a data quality analysis tool (called Achilles Heel) developed by the
Observational Health Data Sciences and Informatics Collaborative (OHDSI) and compare …
Observational Health Data Sciences and Informatics Collaborative (OHDSI) and compare …
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international …
Background In this study we phenotyped individuals hospitalised with coronavirus disease
2019 (COVID-19) in depth, summarising entire medical histories, including medications, as …
2019 (COVID-19) in depth, summarising entire medical histories, including medications, as …
[HTML][HTML] An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza
Background To better understand the profile of individuals with severe coronavirus disease
2019 (COVID-19), we characterised individuals hospitalised with COVID-19 and compared …
2019 (COVID-19), we characterised individuals hospitalised with COVID-19 and compared …
[HTML][HTML] Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure
Observational healthcare databases represent a valuable resource for health economics,
outcomes research, quality of care, drug safety, epidemiology and comparative effectiveness …
outcomes research, quality of care, drug safety, epidemiology and comparative effectiveness …